MNIVF
Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Au… Read more
Market Cap & Net Worth: MNIVF (MNIVF)
MNIVF (PINK:MNIVF) has a market capitalization of $288.33 Million ($288.33 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #16287 globally and #6288 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MNIVF's stock price $0.74 by its total outstanding shares 389634840 (389.63 Million).
MNIVF Market Cap History: 2025 to 2025
MNIVF's market capitalization history from 2025 to 2025. Data shows growth from $288.33 Million to $288.33 Million (0.00% CAGR).
MNIVF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MNIVF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MNIVF by Market Capitalization
Companies near MNIVF in the global market cap rankings as of March 18, 2026.
Key companies related to MNIVF by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
MNIVF Historical Marketcap From 2025 to 2025
Between 2025 and today, MNIVF's market cap moved from $288.33 Million to $ 288.33 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $288.33 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MNIVF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $288.33 Million USD |
| MoneyControl | $288.33 Million USD |
| MarketWatch | $288.33 Million USD |
| marketcap.company | $288.33 Million USD |
| Reuters | $288.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.